GleanMark

EXTENDED BENCH Trademark

EXTENDED BENCH is a USPTO trademark filed by Sterling Pharma Solutions Limited. Status: Pending.

Trademark Facts

MarkEXTENDED BENCH
Serial Number99322680
StatusPending
Filing Date2025-08-06
Mark TypeWord
Nice Classes001 (Chemicals), 005 (Pharmaceuticals), 040 (Material Treatment), 042 (Software & IT)
OwnerSterling Pharma Solutions Limited
Attorney of RecordLaura A. Kees
Prosecution Events21
Latest EventCNEA on 2026-04-24

Goods & Services

Class 001: Chemicals for use in the pharmaceutical industry; active chemical ingredients for use in the manufacture of pharmaceuticals; Class 005: Pharmaceuticals, namely, psychotropics, antihelmintics, anti-infectives, lipid lowering agents, inducers of erections, induction agents, neuromuscular blocking agents, sedatives, anti-cancer medication, anti-inflammatories, anti-fungals, anti-bacterials, anti-spasmodics, appetite stimulants, bronchodilators, appetite suppressants, anti-convulsives, neuroprotective drugs, anti-anxiety medication, anti-depressants, anti-ischemics, anti-psychotics; pharmaceutical preparations for treating diabetes, ear, nose and throat disorders, epilepsy, genetic disorders, hematological disorders, hormonal disorders, infectious diseases, lymphoma, metabolic disorders, mouth and dental disorders, musculoskeletal disorder, non-malignant disorder, nutritional disorders, pain, rare ophthalmological diseases, rare cancers, rare infectious diseases, rare genetic diseases, rare respiratory diseases, rare central nervous system diseases, rare gastrointestinal diseases, rare immunological diseases, rare cardiovascular diseases, rare dermatological diseases, rare urinary system and sex hormone diseases, rare womens health diseases, and rare ear, nose, and throat diseases; pharmaceuticals for medical or veterinary purposes, namely, pharmaceutical preparations and substances for the treatment of viral, infectious, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines; medicine for treating diabetes, ear, nose and throat disorders, epilepsy, genetic disorders, hematological disorders, hormonal disorders, infectious diseases, lymphoma, metabolic disorders, mouth and dental disorders, musculoskeletal disorder, non-malignant disorder, nutritional disorders, pain, rare ophthalmological diseases, rare cancers, rare infectious diseases, rare genetic diseases, rare respiratory diseases, rare central nervous system diseases, rare gastrointestinal diseases, rare immunological diseases, rare cardiovascular diseases, rare dermatological diseases, rare urinary system and sex hormone diseases, rare womens health diseases, and rare ear, nose, and throat diseases; Class 040: Custom manufacturing in the field of pharmaceuticals; processing of pharmaceuticals; custom manufacture of pharmaceuticals; treatment of pharmaceuticals; treatment and disposal being destruction of pharmaceutical waste; information, advice and consultancy services in relation to the aforesaid services; Class 042: Pharmaceutical research services; pharmaceutical development services; pharmaceutical product design services; testing of pharmaceuticals; scientific research in the nature of conducting clinical trials for others relating to pharmaceuticals and chemicals; pharmaceutical analysis, namely, chemical composition analysis, testing, analysis, and evaluation of pharmaceuticals of others to determine conformity with certification standards; pharmaceutical laboratory research services relating to pharmaceuticals; pharmaceutical product evaluation; pharmaceutical reports, namely, preparation of reports relating to pharmaceutical research; inspection of pharmaceuticals; biological research services; quality control and authentication services for others in the field of pharmaceuticals; information, advice and consultancy services in relation to the aforesaid services

Recent Prosecution Activity

DateDocumentType
2026-04-24Examiner's AmendmentEXAMA
2026-04-24Amendment and Mail Process CompleteAMC
2026-04-09TEAS Request Reconsideration after FOARFR
2026-04-09Amendment and Mail Process CompleteAMC
2026-03-23Final ActionFREF
2026-03-18Amendment and Mail Process CompleteAMC

USPTO Refusals on Record

Related